Filing Details
- Accession Number:
- 0001179110-17-011876
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-29 17:24:29
- Reporting Period:
- 2017-08-25
- Accepted Time:
- 2017-08-29 16:24:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537768 | A. Daniel Macuga | 3838 West Parkway Blvd. Salt Lake City UT 84120 | Chief Communications Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-08-25 | 2,077 | $28.81 | 2,077 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-08-25 | 2,077 | $60.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-08-28 | 3,674 | $28.81 | 3,674 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-08-28 | 3,674 | $60.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2017-08-25 | 3,996 | $0.00 | 3,996 | $28.81 |
Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2017-08-28 | 7,068 | $0.00 | 7,068 | $28.81 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,504 | 2016-08-15 | 2018-03-15 | No | 4 | M | Direct |
23,436 | 2016-08-15 | 2018-03-15 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II